Home » WHO Releases Global Guidelines for GLP-1 Medicines in Obesity Treatment
The World Health Organization has issued its first-ever global guidelines for the use of GLP-1 medications to combat obesity, highlighting their potential in weight management.
News Subscription Membership Required
You must be a News Subscription member to access this content.
